Cardiovascular Systems (CSII) Stock Price, News & Analysis

Company Overview

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Key Stats

• Today's Range: $20.00 to $20.00
• 50-Day Range: $19.87 to $20.00
• 52-Week Range: $12.26 to $20.57
• Volume: 4,300 shs
• Average Volume: 765,906 shs
• Market Capitalization: $843.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cardiovascular Systems Stock Analysis - MarketRank™

Cardiovascular Systems scored higher than 13% of companies evaluated by MarketBeat, and ranked 958th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cardiovascular Systems.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cardiovascular Systems are expected to grow in the coming year, from ($0.68) to ($0.51) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cardiovascular Systems has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CSII.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cardiovascular Systems does not currently pay a dividend.

Dividend Growth

Cardiovascular Systems does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -1.05

Short Interest

There is no current short interest data available for CSII.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: -0.11

News Coverage This Week

MarketBeat has tracked 2 news articles for Cardiovascular Systems this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cardiovascular Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.80% of the stock of Cardiovascular Systems is held by insiders.

Percentage Held by Institutions

86.61% of the stock of Cardiovascular Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CSII Stock Analysis - Frequently Asked Questions

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) announced its earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.05. The firm's revenue was up 3.9% compared to the same quarter last year.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD).

Company Calendar

• Last Earnings: 2/08/2023
• Today: 9/20/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:CSII
• CUSIP: 14161910
• CIK: 1180145
• Web: www.csi360.com
• Phone: (651) 259-1600
• Fax: 612-677-3355
• Employees: 780
• Year Founded: 1989

Profitability

• EPS (Most Recent Fiscal Year): ($0.97)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-36,930,000.00
• Net Margins: -15.79%
• Pretax Margin: -15.73%
• Return on Equity: -15.39%
• Return on Assets: -11.93%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 6.04
• Quick Ratio: 4.92

Sales & Book Value

• Annual Sales: $239.84 million
• Price / Sales: 3.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.12 per share
• Price / Book: 3.27

Miscellaneous

• Outstanding Shares: 42,198,000
• Free Float: 40,594,000
• Market Cap: $843.96 million
• Optionable: Optionable
• Beta: 0.74